C07K 14/09
Foot-and-mouth disease virus
C07K14/09 (Foot-and-mouth disease virus) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C07K- Granted patents
- 3
- Published applications
- 5
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and uses thereof18 Mar 2025US 12,251,435 B2Beijing Minhai Biotechnology Co., Ltd.
- Synthetic polypeptide epitope based vaccine composition15 Mar 2022US 11,273,215 B2Bharat Biotech International Limited
- Adenoviral vector system for gene delivery6 Apr 2021US 10,968,464 B2Purdue Research Foundation
- Gene sequence construct used for treatment of central nervous system diseases30 Apr 2026US 2026/0117234 A1
- Hansenula engineering fungi efficiently expressing ca10 virus-like particles and use thereof21 Apr 2022US 2022/0118075 A1Beijing Minhai Biotechnology Co., Ltd.
- A synthetic polypeptide epitope based vaccine composition22 Jul 2021US 2021/0220466 A1Bharat Biotech International Limited
- Novel adenoviral vector system for gene delivery26 Sep 2019US 2019/0292562 A1Purdue Research Foundation
- Foot and mouth disease virus serotype o (fmdv-o) vaccine12 Sep 2019US 2019/0275138 A1The Wistar Institute of Anatomy and Biology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.